Platelet Microparticles-Containing Mir-4306 Inhibits Human Monocyte-Derived Macrophages Migration Through VEGFA/ERK1/2/NF-κB Signaling Pathways

Ying Yang,Hui Luo,Si Liu,Rongyi Zhang,Xiao Zhu,Murong Liu,Houxiang Hu,Yi Yang,Zhan Lv,Mao Chen
DOI: https://doi.org/10.1080/10641963.2018.1510941
2018-01-01
Clinical and Experimental Hypertension
Abstract:Platelets are major sources of microparticles (MPs) in peripheral bloodstream, and platelet-secreted MPs (P-MPs) transfer biological information to neighboring cells. In the present study, we found that the platelet- and P-MPs-derived microRNA-4306 (miR-4306) expression were downregulated in coronary artery disease (CAD) and platelet-derived miR-4306 was an independent poor prognostic factor in CAD. Plasma miRNA-4306 mainly cofractionated with MPs instead of Argonaute2 complexes or HDL. P-MPs could effectively deliver miR-4306 into human monocyte-derived macrophages (HMDMs). MiR-4306 noticeably inhibited the HMDMs migration in vitro and reduced the number of macrophage cells in cardiac tissue in myocardial infarction mice. This functional impact of miR-4306 was mediated directly through VEGFA to inhibit ERK/NF-κB signaling. In conclusion, our study suggested that intercellular transfer of miR-4306 by platelet microparticles inhibited the HMDMs migration through VEGFA/ERK1/2/NF-κB signaling pathways.
What problem does this paper attempt to address?